Shell Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Sell |
|
|||||
|
2025
Q1 | $591K | Sell |
|
|||||
|
2024
Q4 | $529K | Sell |
|
|||||
|
2024
Q3 | $505K | Buy |
|
|||||
|
2024
Q1 | $448K | Sell |
|
|||||
|
2023
Q4 | $534K | Sell |
|
|||||
|
2023
Q3 | $483K | Sell |
|
|||||
|
2023
Q2 | $646K | Sell |
|
|||||
|
2023
Q1 | $845K | Sell |
|
|||||
|
2022
Q4 | $952K | Sell |
|
|||||
|
2022
Q3 | $793K | Sell |
|
|||||
|
2022
Q2 | $547K | Buy |
|
|||||
|
2022
Q1 | $646K | Sell |
|
|||||
|
2021
Q4 | $605K | Buy |
|
|||||
|
2021
Q3 | $472K | Sell |
|
|||||
|
2021
Q2 | $534K | Buy |
|
|||||
|
2021
Q1 | $255K | Buy |
|